Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Daniel Teper | M | 64 |
Vector Therapeutics, Inc.
 Vector Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Vector Therapeutics, Inc. is a commercial-stage specialty pharmaceutical company. The firm engages in the acquisition, development, and commercialization of treatments for a variety of cancers, with a primary focus on leukemia. Its product portfolio consists initially of drugs targeting different stages and sub-types of Acute Myeloid Leukemia. The company was founded by Daniel Teper and is headquartered in New York, NY.
Cytovia Therapeutics, Inc.
 Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | - |
| Armin V. Rath | M | - |
Vector Therapeutics, Inc.
Vector Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Vector Therapeutics, Inc. is a commercial-stage specialty pharmaceutical company. The firm engages in the acquisition, development, and commercialization of treatments for a variety of cancers, with a primary focus on leukemia. Its product portfolio consists initially of drugs targeting different stages and sub-types of Acute Myeloid Leukemia. The company was founded by Daniel Teper and is headquartered in New York, NY.
Cytovia Therapeutics, Inc.
Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | - |
| Thomas H. Robinson | M | 65 |
Vector Therapeutics, Inc.
Vector Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Vector Therapeutics, Inc. is a commercial-stage specialty pharmaceutical company. The firm engages in the acquisition, development, and commercialization of treatments for a variety of cancers, with a primary focus on leukemia. Its product portfolio consists initially of drugs targeting different stages and sub-types of Acute Myeloid Leukemia. The company was founded by Daniel Teper and is headquartered in New York, NY.
Cytovia Therapeutics, Inc.
Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | - |
| Michael Friedman | M | 80 |
Cytovia Therapeutics, Inc.
Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | - |
| Laurent Audoly | M | - |
Cytovia Therapeutics, Inc.
Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | - |
| Alexander Mencik | M | 55 |
Vector Therapeutics, Inc.
Vector Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Vector Therapeutics, Inc. is a commercial-stage specialty pharmaceutical company. The firm engages in the acquisition, development, and commercialization of treatments for a variety of cancers, with a primary focus on leukemia. Its product portfolio consists initially of drugs targeting different stages and sub-types of Acute Myeloid Leukemia. The company was founded by Daniel Teper and is headquartered in New York, NY. | - |
| Anna Baran-Djokovic | F | - |
Cytovia Therapeutics, Inc.
Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | - |
| Jason Aryeh | M | 55 |
Cytovia Therapeutics, Inc.
Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | 3 Jahre |
| Stanley Frankel | M | 65 |
Cytovia Therapeutics, Inc.
Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | 3 Jahre |
| Olivier Gouédard | M | - |
Cytovia Therapeutics, Inc.
Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | 3 Jahre |
| Kaouthar Lbiati | M | 45 |
Cytovia Therapeutics, Inc.
Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 11 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Gilles Seydoux
- Persönliches Netzwerk
